Version BIOiSIM - Virtual Drug Development Engine Software
BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illness or disease.
We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.
Our models are built on data from thousands of compounds across 7 species, leading to a robustness rarely seen in the industry.
With a focus on human outcomes, the platform has at its core a translability engine that transforms insights across species.
The BIOiSIMTM platform can be used before preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation.
The team employees a continuous improvement process to iterate on data stability, improve models, and provide an always up-to-date software service.
ARTIFICIAL INTELLIGENCE AND MECHANISTIC MODELS
VSL has shown that the best models are developed by using a hybrid mixed-model approach to drug insights, leading to greater accuracy and scalability.
FAST MODEL DEVELOPMENT
The flexibility of the platform and generations of customer-ready tools allows for development of custom models and validations within weeks.
Specific to desired output
With our framework, we can quickly develop custom, specific models.
Multiple routes of administration
We simulate various routes of administrations such as IV, oral, and transdermal and others.
Trained on diverse data across various animal and human species
Validated with both FDA and proprietary compounds.
Rapid result generation
Our platform is cloud-based and generates predictions in seconds.
Expanding feature set
We are always adding new functionality and expanding the domain of applicability.
Our model extracts conclusions from complex and convoluted data.